Migration notice:
On August 9th, 2025, Finsight.com market data will be renamed and migrated to CreditFlow, a more intuitive, comprehensive and accessible market data platform for all credit products.
Contact us
for more information.
Market Data
Pricing
Solutions
Log In
Market Overview
Financials
Asset Management & Custody Banks
Parent Companies
Taizhou Huaxin Pharmaceutical Investment Co Ltd
Huaxin Pharmaceutical Hong Kong Co Ltd
2023-1
Huaxin Pharmaceutical Hong Kong Co Ltd (HAXNP) 2023-1
C/P
Sector
Status
Deal Name
Parent
Leads
Region
Date
HYC
FNCL
PRCD
HAXNP 2023-1 (USD 42m)
Taizhou Huaxin Pharmaceutical Investment Co Ltd
ABC
,
CTC
,
CHK
,
CMB
,
...
APAC
Dec 5, 2023
CCY
SIZE (M)
TNR
MTY
RNK
MO
SP
FI
TYPE
BNCH
IPT
GDNC
SPRD
CPN
NIC
PRICE
WNJ
21.000
8
Sep-18
Eablyz
-
-
-
Tmgcn
ELB
6.20% r
-
-
6.00%
-
822.00000
Tranche Comments
3 bf: Registration: Gdp S Sibi; Comments: IUZ42m 3jx QxbU. Iyuzn Xnxxxnsxoynsg Uxuzxoxoxu/XCMCX/CVMX/Czs Bos/XnozuxxosgCX/CXMXC/RMCX/CNCMCsp/Xnoxosg Cspoxsg/Jzyjzsn Uxuzxoxoxu/JI Uxu/Jxx Co Xnxxxnsxoynsg Uxuzxoxoxu (Cynb Xynb). XIJ Xgo 6.2% sxxs, oonsg Xgo 6%. INXq 30030085IGZ266MM8N23;
Guarantor(s)
Zanrpwz Wzahnk Ppayiahiznnhar Zkainniikn Mw Nnb
Use of Proceeds
Wuljp cjjyhcsu suih
Commentary
Upgrade Plan
Deal Flow
Upgrade Plan
Missing something? Tell us.